InsiderTrades.com logo

QNRX Insider Trading

Insider Ownership Percentage: 13.46%
Insider Buying (Last 12 Months): $128,640.48
Insider Selling (Last 12 Months): $0.00

Quoin Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Quoin Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quoin Pharmaceuticals Share Price & Price History

Current Price: $5.90
Price Change: ▲ Price Increase of +0.16 (2.79%)
As of 04/10/2026 05:00 PM ET

This chart shows the closing price history over time for QNRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Quoin Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/14/2025Dennis LangerDirectorBuy15,152$8.49$128,640.4815,153View SEC Filing Icon  
12/23/2024Anthony James CulverwellDirectorBuy2,857$15.75$44,997.752,866View SEC Filing Icon  
12/23/2024Denise P CarterCOOBuy15,873$15.75$249,999.7517,218View SEC Filing Icon  
12/23/2024Gordon DunnCFOBuy3,492$15.75$54,999.004,316View SEC Filing Icon  
9/9/2024Gordon DunnCFOBuy253$27.65$6,995.45253View SEC Filing Icon  
9/4/2024Denise P CarterCOOBuy908$27.30$24,788.401,345View SEC Filing Icon  
9/3/2024Michael MyersCEOBuy22$21.70$477.40290View SEC Filing Icon  
6/7/2024Dennis LangerDirectorSell8$25.55$204.401View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Quoin Pharmaceuticals (NASDAQ:QNRX)

8.63% of Quoin Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at QNRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Quoin Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC211,538$3.05M0.2%N/A25.183%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.64,795$0.94M0.0%N/A7.714%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC74,817$1.08M0.0%N/A8.907%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC59,838$0.86M0.0%N/A7.124%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC58,230$0.84M0.1%N/A6.932%Search for SEC Filing on Google Icon
2/9/2026Simplify Asset Management Inc.17,448$0.25M0.0%N/A2.077%Search for SEC Filing on Google Icon
2/2/2026AIGH Capital Management LLC49,323$0.71M0.2%N/A5.872%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc75,000$1.08M0.0%N/A8.929%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC2,084$30K0.0%+649.6%0.248%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC80,712$53K0.0%N/A1.598%Search for SEC Filing on Google Icon
2/14/2025Altium Capital Management LLC282,249$0.18M0.1%N/A5.589%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC133,122$87K0.0%+244.1%2.636%Search for SEC Filing on Google Icon
1/28/2025Apollon Wealth Management LLC80,025$52K0.0%N/A1.585%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC30,749$29K0.0%N/A0.773%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC147,907$70K0.0%N/A3.050%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC29,865$67K0.0%N/A2.948%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Quoin Pharmaceuticals logo
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.
Read More on Quoin Pharmaceuticals

Today's Range

Now: $5.90
Low: $5.59
High: $6.24

50 Day Range

MA: $7.85
Low: $5.74
High: $9.47

52 Week Range

Now: $5.90
Low: $5.01
High: $41.80

Volume

9,118 shs

Average Volume

245,722 shs

Market Capitalization

$4.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61

Who are the company insiders with the largest holdings of Quoin Pharmaceuticals?

Quoin Pharmaceuticals' top insider investors include:
  1. Denise P Carter (COO)
  2. Dennis Langer (Director)
  3. Gordon Dunn (CFO)
  4. Anthony James Culverwell (Director)
  5. Michael Myers (CEO)
Learn More about top insider investors at Quoin Pharmaceuticals.